Recombinant SARS-Cov-2 Spike protein RBD (EG.5), (HEK293)
Product Specifications
Background
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Gene ID
43740568
Swiss Prot
P0DTC2
Expression System
HEK293
Conjugation
Unconjugated
Tag
C-His
Source
Recombinant SARS-Cov-2 Spike protein RBD (EG.5) is expressed in HEK293 cell with C-His. It contains the amino acid sequence of 319-537/1273
Applications
Others
Endotoxin
Not Tested
Purity
> 90% as determined by SDS- PAGE
Buffer
0.01M TBS (pH7.4)
Storage Conditions
The product should be stored at -70°C or -20°C.
Species
Others
Gene ID URL
43740568
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1130246-01 0.02 mg (Mammalian-Cell)
Recombinant Human Interleukin-13 (IL13)
Sign In for Pricing
View Details 
MBS1130246-02 0.1 mg (Mammalian-Cell)
Recombinant Human Interleukin-13 (IL13)
Sign In for Pricing
View Details MBS1130246-03 0.02 mg (E-Coli)
Recombinant Human Interleukin-13 (IL13)
Sign In for Pricing
View Details 
MBS1130246-04 0.02 mg (Yeast)
Recombinant Human Interleukin-13 (IL13)
Sign In for Pricing
View Details MBS1130246-05 0.1 mg (E-Coli)
Recombinant Human Interleukin-13 (IL13)
Sign In for Pricing
View Details